Startups
Rhizen is a pharmaceutical R&D company focused on discovery and development of innovative, small molecule drugs.
Overview
Employees
11-50
Founded date
2012
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 14, 2020 | Rhizen enters into licensing agreement with Chinese biopharmaceutical company | |
| Oct 14, 2020 | Rhizen enters into licensing agreement with Chinese biopharmaceutical company | Curon obtains the exclusive development and commercialization rights of Tenalisib for Greater China across all oncology indications, and will lead the clinical development in that territory by leveraging its unique expertise in translationa... |
Reviews 0
FAQ about Rhizen
When was Rhizen founded?
Rhizen was founded in 2012.
What has the press written about Rhizen?
Parsers VC has collected 3 articles mentioning Rhizen, among them “Rhizen enters into licensing agreement with Chinese biopharmaceutical company” (Oct 14, 2020) and “Rhizen enters into licensing agreement with Chinese biopharmaceutical company” (Oct 14, 2020).
Is Rhizen still active?
Yes, Rhizen is active; its latest activity on Parsers VC dates from Nov 11, 2021.